Regend Therapeutics
PrivateLast Round
Series B
Mar 3, 2022
Total Funding Raised
$17.68M
Company Overview
Regend Therapeutics is a Chinese biotechnology company that specializes in organ regeneration through progenitor cell-based regenerative medicine. The company's work focuses on developing treatments for severe respiratory diseases like idiopathic pulmonary fibrosis (IPF) and bronchiectasis. It has established a complete industrial chain, including preclinical research centers, a GMP pilot research base, and a GMP progenitor cell production and storage facility. Regend Therapeutics is actively conducting clinical trials, including a Phase II study for its lead product, REGEND001, for IPF. The company has received venture capital funding to support its research and development programs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regend Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Regend Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 3, 2022 | ||||
| Angel | Aug 6, 2015 |
Regend Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| China Merchants Securities | Series B |
| Soochow Securities | Series B |
| Wanrong Hongtu | Series B |
| West Fountain Capital Management Limited | Series B |
| Shenzhen Capital Group | Series B |
Regend Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Regend Therapeutics's valuation, stock price, and market status.
